IMRIS, Inc. (IMRS) was a big mover last session, as its shares rose nearly 9% on the day. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $1.30 to $1.46 in the past one-month time frame.
In the last 30-day frame, the company did not witness any estimate revision while the Zacks Consensus Estimate moved higher. The recent rally is encouraging though, so make sure to keep a close watch on this firm in the near future.
IMRIS currently has a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%.
Some other medical stocks worth considering include Lannett Company, Inc. (LCI), Jazz Pharmaceuticals plc (JAZZ) and Questcor Pharmaceuticals, Inc. (QCOR). All these companies carry a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
(IMRS): Free Stock Analysis Report
LANNETT COMP (LCI): Free Stock Analysis Report
JAZZ PHARMACEUTICALS PLC IRELAND (JAZZ): Free Stock Analysis Report
QUESTCOR PHARMACEUTICALS INC (QCOR): Free Stock Analysis Report
Zacks Investment Research
- Personal Investing Ideas & Strategies
- Finance Trading